Memory Th17 Cell-mediated Protection Against Lethal Secondary Pneumococcal Pneumonia Following Influenza Infection

Overview

Journal mBio

Publisher American Society for Microbiology

Specialty Microbiology

Date 2023 May 24

PMID 37222516

Authors

Yong Li

Ying Yang

Dafan Chen

Yan Wang

Xinyun Zhang

Wenchao Li

Shengsen Chen

Sandy M Wong

Mengwen Shen

Brian J Akerley

Hao Shen

Affiliations

Soon will be listed here.

Abstract

() frequently causes secondary pneumonia after influenza A virus (IAV) infection, leading to high morbidity and mortality worldwide. Concomitant pneumococcal and influenza vaccination improves protection against coinfection but does not always yield complete protection. Impaired innate and adaptive immune responses have been associated with attenuated bacterial clearance in influenza virus-infected hosts. In this study, we showed that preceding low-dose IAV infection caused persistent infection and suppression of bacteria-specific T-helper type 17 (Th17) responses in mice. Prior infection protected against subsequent IAV/ coinfection by improving bacterial clearance and rescuing bacteria-specific Th17 responses in the lungs. Furthermore, blockade of IL-17A by anti-IL-17A antibodies abrogated the protective effect of preinfection. Importantly, memory Th17 responses induced by preinfection overcame viral-driven Th17 inhibition and provided cross-protection against different serotypes following coinfection with IAV. These results indicate that bacteria-specific Th17 memory cells play a key role in providing protection against IAV/ coinfection in a serotype-independent manner and suggest that a Th17-based vaccine would have excellent potential to mitigate disease caused by coinfection. IMPORTANCE () frequently causes secondary bacterial pneumonia after influenza A virus (IAV) infection, leading to increased morbidity and mortality worldwide. Current pneumococcal vaccines induce highly strain-specific antibody responses and provide limited protection against IAV/ coinfection. Th17 responses are broadly protective against single infection, but whether the Th17 response, which is dramatically impaired by IAV infection in naïve mice, might be effective in immunization-induced protection against pneumonia caused by coinfection is not known. In this study, we have revealed that -specific memory Th17 cells rescue IAV-driven inhibition and provide cross-protection against subsequent lethal coinfection with IAV and different serotypes. These results indicate that a Th17-based vaccine would have excellent potential to mitigate disease caused by IAV/ coinfection.

References

Stritesky G, Yeh N, Kaplan M . IL-23 promotes maintenance but not commitment to the Th17 lineage. J Immunol. 2008; 181(9):5948-55. PMC: 2678905. DOI: 10.4049/jimmunol.181.9.5948. View

Braverman J, Monk I, Ge C, Westall G, Stinear T, Wakim L . Staphylococcus aureus specific lung resident memory CD4 Th1 cells attenuate the severity of influenza virus induced secondary bacterial pneumonia. Mucosal Immunol. 2022; 15(4):783-796. PMC: 9148937. DOI: 10.1038/s41385-022-00529-4. View

Monticelli L, Sonnenberg G, Abt M, Alenghat T, Ziegler C, Doering T . Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus. Nat Immunol. 2011; 12(11):1045-54. PMC: 3320042. DOI: 10.1031/ni.2131. View

Robinson K, Choi S, McHugh K, Mandalapu S, Enelow R, Kolls J . Influenza A exacerbates Staphylococcus aureus pneumonia by attenuating IL-1β production in mice. J Immunol. 2013; 191(10):5153-9. PMC: 3827735. DOI: 10.4049/jimmunol.1301237. View

Rathore J, Wang Y . Protective role of Th17 cells in pulmonary infection. Vaccine. 2016; 34(13):1504-1514. DOI: 10.1016/j.vaccine.2016.02.021. View

Shahangian A, Chow E, Tian X, Kang J, Ghaffari A, Liu S . Type I IFNs mediate development of postinfluenza bacterial pneumonia in mice. J Clin Invest. 2009; 119(7):1910-20. PMC: 2701856. DOI: 10.1172/JCI35412. View

DeMuri G, Gern J, Eickhoff J, Lynch S, Wald E . Dynamics of Bacterial Colonization With Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis During Symptomatic and Asymptomatic Viral Upper Respiratory Tract Infection. Clin Infect Dis. 2017; 66(7):1045-1053. PMC: 6019034. DOI: 10.1093/cid/cix941. View

Jirru E, Lee S, Harris R, Yang J, Cho S, Stout-Delgado H . Impact of Influenza on Pneumococcal Vaccine Effectiveness during Infection in Aged Murine Lung. Vaccines (Basel). 2020; 8(2). PMC: 7349919. DOI: 10.3390/vaccines8020298. View

Klein E, Monteforte B, Gupta A, Jiang W, May L, Hsieh Y . The frequency of influenza and bacterial coinfection: a systematic review and meta-analysis. Influenza Other Respir Viruses. 2016; 10(5):394-403. PMC: 4947938. DOI: 10.1111/irv.12398. View

10.

Monsalvo A, Batalle J, Lopez M, Krause J, Klemenc J, Hernandez J . Severe pandemic 2009 H1N1 influenza disease due to pathogenic immune complexes. Nat Med. 2010; 17(2):195-9. PMC: 3034774. DOI: 10.1038/nm.2262. View

11.

Hahn I, Klaus A, Janze A, Steinwede K, Ding N, Bohling J . Cathepsin G and neutrophil elastase play critical and nonredundant roles in lung-protective immunity against Streptococcus pneumoniae in mice. Infect Immun. 2011; 79(12):4893-901. PMC: 3232647. DOI: 10.1128/IAI.05593-11. View

12.

Teng F, Liu X, Guo S, Li Z, Ji W, Zhang F . Community-acquired bacterial co-infection predicts severity and mortality in influenza-associated pneumonia admitted patients. J Infect Chemother. 2018; 25(2):129-136. DOI: 10.1016/j.jiac.2018.10.014. View

13.

Chen K, McAleer J, Lin Y, Paterson D, Zheng M, Alcorn J . Th17 cells mediate clade-specific, serotype-independent mucosal immunity. Immunity. 2011; 35(6):997-1009. PMC: 3406408. DOI: 10.1016/j.immuni.2011.10.018. View

14.

Fineberg H . Pandemic preparedness and response--lessons from the H1N1 influenza of 2009. N Engl J Med. 2014; 370(14):1335-42. DOI: 10.1056/NEJMra1208802. View

15.

Robinson K, Kolls J, Alcorn J . The immunology of influenza virus-associated bacterial pneumonia. Curr Opin Immunol. 2015; 34:59-67. PMC: 4444379. DOI: 10.1016/j.coi.2015.02.002. View

16.

Kuipers K, Jong W, van der Gaast-de Jongh C, Houben D, van Opzeeland F, Simonetti E . Th17-Mediated Cross Protection against Pneumococcal Carriage by Vaccination with a Variable Antigen. Infect Immun. 2017; 85(10). PMC: 5607416. DOI: 10.1128/IAI.00281-17. View

17.

Kadioglu A, Weiser J, Paton J, Andrew P . The role of Streptococcus pneumoniae virulence factors in host respiratory colonization and disease. Nat Rev Microbiol. 2008; 6(4):288-301. DOI: 10.1038/nrmicro1871. View

18.

Nakamura S, Davis K, Weiser J . Synergistic stimulation of type I interferons during influenza virus coinfection promotes Streptococcus pneumoniae colonization in mice. J Clin Invest. 2011; 121(9):3657-65. PMC: 3163966. DOI: 10.1172/JCI57762. View

19.

Furuya-Kanamori L, Cox M, Milinovich G, Soares Magalhaes R, Mackay I, Yakob L . Heterogeneous and Dynamic Prevalence of Asymptomatic Influenza Virus Infections. Emerg Infect Dis. 2016; 22(6):1052-6. PMC: 4880086. DOI: 10.3201/eid2206.151080. View

20.

Podsiad A, Standiford T, Ballinger M, Eakin R, Park P, Kunkel S . MicroRNA-155 regulates host immune response to postviral bacterial pneumonia via IL-23/IL-17 pathway. Am J Physiol Lung Cell Mol Physiol. 2015; 310(5):L465-75. PMC: 4773845. DOI: 10.1152/ajplung.00224.2015. View